The hallmarks of cancer, Cell, vol.100, pp.57-70, 2000. ,
Checkpoints: controls that ensure the order of cell cycle events, Science, vol.246, pp.629-663, 1989. ,
RB and cell cycle progression, Oncogene, vol.25, pp.5220-5227, 2006. ,
The retinoblastoma protein and cell cycle control, Cell, vol.81, pp.323-353, 1995. ,
DP and E2F proteins: coordinating transcription with cell cycle progression, Curr Opin Cell Biol, vol.6, pp.859-66, 1994. ,
Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G 1, Cell, vol.98, pp.859-69, 1999. ,
CDK inhibitors: positive and negative regulators of G 1 -phase progression, Genes Dev, vol.13, pp.1501-1513, 1999. ,
Mammalian cyclin-dependent kinases, Trends Biochem Sci, vol.30, pp.630-671, 2005. ,
Aurora-A: the maker and breaker of spindle poles, J Cell Sci, vol.120, pp.2987-96, 2007. ,
Polo-like kinases: conservation and divergence in their functions and regulation, Nat Rev Mol Cell Biol, vol.10, pp.265-75, 2009. ,
Aurora-A-a guardian of poles, Nat Rev Cancer, vol.5, pp.42-50, 2005. ,
The chromosomal passenger complex: guiding Aurora-B through mitosis, J Cell Biol, vol.173, pp.833-840, 2006. ,
Dynamic localization and functional implications of Aurora-C kinase during male mouse meiosis, Dev Biol, vol.290, pp.398-410, 2006. ,
Aurora-C kinase is a novel chromosomal passenger protein that can complement Aurora-B kinase function in mitotic cells, Cell Motil Cytoskeleton, vol.59, pp.249-63, 2004. ,
Targeting polo-like kinase 1 for cancer therapy, Nat Rev Cancer, vol.6, pp.321-351, 2006. ,
Polo-like kinases and the orchestration of cell division, Nat Rev Mol Cell Biol, vol.5, pp.429-469, 2004. ,
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis, Nature, vol.434, pp.864-70, 2005. ,
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions, Nature, vol.434, pp.907-920, 2005. ,
ATM and related protein kinases: safeguarding genome integrity, Nat Rev Cancer, vol.3, pp.155-68, 2003. ,
Multiple genetic alterations in smallcell lung carcinoma, Princess Takamatsu Symp, vol.20, pp.43-51, 1989. ,
Abnormalities in structure and expression of the human retinoblastoma gene in SCLC, Science, vol.241, pp.353-360, 1988. ,
Mechanism of retinoblastoma gene inactivation in the spectrum of neuroendocrine lung tumors, Am J Respir Cell Mol Biol, vol.18, pp.188-96, 1998. ,
Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuro-endocrine lung carcinomas, Int J Cancer, vol.58, pp.818-842, 1994. ,
Ki-67 expression and prognosis for smokers with resected stage I non-small cell lung cancer, Ann Thorac Surg, vol.75, pp.1727-1759, 2003. ,
Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group, Oncogene, vol.8, pp.1913-1922, 1993. ,
The cyclin-dependent kinase inhibitor p27 as a prognostic factor in advanced non-small cell lung cancer: its immunohistochemical evaluation using biopsy specimens, Lung Cancer, vol.26, pp.187-94, 1999. ,
p27 KIP1 in human lung cancers: differential changes in small cell and non-small cell carcinomas, Cancer Res, vol.58, pp.1042-1049, 1998. ,
Protective function of p27(KIP1) against apoptosis in small cell lung cancer cells in unfavorable microenvironments, Am J Pathol, vol.158, pp.87-96, 2001. ,
Prognostic role of the cyclindependent kinase inhibitor p27 in non-small cell lung cancer, Cancer Res, vol.57, pp.3381-3386, 1997. ,
A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers, Am J Pathol, vol.161, pp.207-223, 2002. ,
E2F-1, Skp2 and cyclin E oncoproteins are upregulated and directly correlated in high-grade neuroendocrine lung tumors, Oncogene, vol.26, pp.6927-6963, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00173067
Downregulation of the KIP family members p27(KIP1) and p57(KIP2) by SKP2 and the role of methylation in p57(KIP2) inactivation in nonsmall cell lung cancer, Int J Cancer, vol.119, pp.2546-56, 2006. ,
Aberrant methylation of p57 KIP2 gene in lung and breast cancers and malignant mesotheliomas, Oncol Rep, vol.12, pp.1087-92, 2004. ,
Emerging roles of E2Fs in cancer: an exit from cell cycle control, Nat Rev Cancer, vol.9, pp.785-97, 2009. ,
Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma, Oncogene, vol.20, pp.1678-87, 2001. ,
High-resolution genomic profiles of human lung cancer, Proc Natl Acad Sci, vol.102, pp.9625-9655, 2005. ,
Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas, J Pathol, vol.198, pp.142-56, 2002. ,
E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer, Clin Cancer Res, vol.13, pp.6938-6984, 2007. ,
Overexpression of the replication licensing regulators hCdt1 and hCdc6 characterizes a subset of non-small-cell lung carcinomas: synergistic effect with mutant p53 on tumor growth and chromosomal instability-evidence of E2F-1 transcriptional control over hCdt1, Am J Pathol, vol.165, pp.1351-65, 2004. ,
Overexpression of E2F1 associated with LOH at RB locus and hyperphosphorylation of RB in non-small cell lung carcinoma, J Cancer Res Clin Oncol, vol.130, pp.320-326, 2004. ,
Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization, Cancer Res, vol.54, pp.1801-1807, 1994. ,
Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers, Clin Cancer Res, vol.1, pp.687-90, 1995. ,
Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma, Cancer Res, vol.55, pp.2968-71, 1995. ,
Association of CDKN2A(p16)/CDKN2B(p15) alterations and homozygous chromosome arm 9p deletions in human lung carcinoma, Genes Chromosomes Cancer, vol.22, pp.232-272, 1998. ,
Hypermethylation-associated inactivation indicates a tumor suppressor role for p15 INK4B, Cancer Res, vol.56, pp.722-729, 1996. ,
Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma, Pathol Int, vol.54, pp.549-55, 2004. ,
Mutations in the p16 INK4 /MTS1/CDKN2, p15 INK4B /MTS2 and p18 genes in primary and metastatic lung cancer, Cancer Res, vol.55, pp.1448-51, 1995. ,
Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers, Int J Cancer, vol.65, pp.734-743, 1996. ,
Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status, Oncogene, vol.20, pp.6587-96, 2001. ,
Molecular analysis of a family of cyclin-dependent kinase inhibitor genes (p15/MTS2/INK4b and p18/INK4c) in nonsmall cell lung cancers, Mol Carcinog, vol.14, pp.263-271, 1995. ,
p18 Ink4c collaborates with Men1 to constrain lung stem cell expansion and suppress non-small-cell lung cancers, Cancer Res, vol.67, pp.3162-70, 2007. ,
p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung, Clin Cancer Res, vol.3, pp.1831-1836, 1997. ,
Clinical significance of p21 expression in non-small-cell lung cancer, J Clin Oncol, vol.20, pp.3865-71, 2002. ,
Analysis of cell cycle regulator proteins in non-small cell lung cancer, J Clin Pathol, vol.57, pp.58-63, 2004. ,
Reduced expression of the cell cycle inhibitor p27 Kip1 in non-small cell lung carcinoma: a prognostic factor independent of Ras, Cancer Res, vol.59, pp.684-692, 1999. ,
High cyclin E and low p27/Kip1 expressions are potentially poor prognostic factors in lung adenocarcinoma patients, Lung Cancer, vol.34, pp.59-65, 2001. ,
Relationship between postoperative recurrence and expression of cyclin E, p27 and Ki-67 in non-small cell lung cancer without lymph node metastases, Int J Clin Oncol, vol.7, pp.349-55, 2002. ,
Reduced expression of cell cycle regulator p27(Kip1) correlates with a shortened survival in non-small cell lung cancer, Lung Cancer, vol.34, pp.83-90, 2001. ,
A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers, J Thorac Cardiovasc Surg, vol.117, pp.736-779, 1999. ,
Mutations in the retinoblastomarelated gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer, Cancer Res, vol.60, pp.372-82, 2000. ,
Differential expression of Rb2/ p130 and p107 in normal human tissues and in primary lung cancer, Clin Cancer Res, vol.3, pp.1691-1698, 1997. ,
Differential expression of the retinoblastoma gene family members pRb/p105, p107 and pRb2/p130 in lung cancer, Clin Cancer Res, vol.2, pp.1239-1284, 1996. ,
Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma, Proc Natl Acad Sci, vol.94, pp.6933-6941, 1997. ,
Reciprocal Rb inactivation and p16 INK4 expression in primary lung cancers and cell lines, Cancer Res, vol.55, pp.505-514, 1995. ,
Mechanisms of p16 INK4A inactivation in non smallcell lung cancers, Oncogene, vol.16, pp.497-504, 1998. ,
Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene, Cancer Res, vol.57, pp.1-6, 1997. ,
Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis, Proc Natl Acad Sci, vol.95, pp.11891-11897, 1998. ,
Prognostic implications of cell cycle, apoptosis and angiogenesis biomarkers in non-small cell lung cancer: a review, Clin Cancer Res, vol.11, pp.3974-86, 2005. ,
Cyclin D1 and retinoblastoma susceptibility gene alterations in non-small cell lung cancer, Int J Cancer, vol.75, pp.187-92, 1998. ,
Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer, Br J Cancer, vol.73, pp.294-300, 1996. ,
Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation, Lung Cancer, vol.55, pp.1-14, 2007. ,
Alterations of Rb pathway (Rb-p16 INK4 -cyclin D1) in preinvasive bronchial lesions, Clin Cancer Res, vol.5, pp.243-50, 1999. ,
Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer, Clin Cancer Res, vol.9, pp.2195-203, 2003. ,
Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II, Lung Cancer, vol.34, pp.207-225, 2001. ,
CDK4 is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer, Genes Chromosomes Cancer, vol.42, pp.193-202, 2005. ,
Epigenetic inactivation of checkpoint kinase 2 gene in non-small cell lung cancer and its relationship with clinicopathological features, Lung Cancer, vol.65, pp.247-50, 2009. ,
Histological type-selective, tumorpredominant expression of a novel CHK1 isoform and infrequent in vivo somatic CHK2 mutation in small cell lung cancer, Cancer Res, vol.60, pp.4689-92, 2000. ,
Somatic mutation of the hBUB1 mitotic checkpoint gene in primary lung cancer, Genes Chromosomes Cancer, vol.29, pp.213-221, 2000. ,
Search for in vivo somatic mutations in the mitotic checkpoint gene, hMAD1, in human lung cancers, Oncogene, vol.18, pp.7180-7183, 1999. ,
MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells, Nature, vol.409, pp.355-364, 2001. ,
Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation, J Cell Biol, vol.160, pp.341-53, 2003. ,
Cell cycle kinases as therapeutic targets for cancer, Nat Rev Drug Discov, vol.8, pp.547-66, 2009. ,
Statistical issues in translational cancer research, Clin Cancer Res, vol.14, pp.5954-5962, 2008. ,
The small-molecule CDK inhibitor, SNS-032, enhances cellular radiosensitivity in quiescent and hypoxic non-small cell lung cancer cells, Lung Cancer, vol.66, pp.37-47, 2009. ,
A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days, Br J Cancer, vol.96, pp.29-37, 2007. ,
VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo, Nat Med, vol.10, pp.262-269, 2004. ,
Identification and characterization of a novel and specific inhibitor of the ataxiatelangiectasia mutated kinase ATM, Cancer Res, vol.64, pp.9152-9161, 2004. ,
Transient inhibition of ATM kinase is sufficient to enhance cellular sensitivity to ionizing radiation, Cancer Res, vol.68, pp.7466-74, 2008. ,
Polymorphisms of STK15 (Aurora-A) gene and lung cancer risk in Caucasians, Carcinogenesis, vol.28, pp.350-355, 2007. ,
Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability, Br J Cancer, vol.93, pp.719-748, 2005. ,
Expression profiling of primary non-small cell lung cancer for target identification, Oncogene, vol.21, pp.7749-63, 2002. ,
Frequent overexpression of aurora B kinase, a novel drug target, in non-small cell lung carcinoma patients, Mol Cancer Ther, vol.5, pp.2905-2918, 2006. ,
Expression of transforming acidic coiled-coil containing protein 3 is a novel independent prognostic marker in non-small cell lung cancer, Pathol Int, vol.56, pp.503-512, 2006. ,
Expression of targeting protein for xklp2 associated with both malignant transformation of respiratory epithelium and progression of squamous cell lung cancer, Clin Cancer Res, vol.12, pp.1121-1128, 2006. ,
Frequent hypermethylation of the 5' CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer, Carcinogenesis, vol.24, pp.47-51, 2003. ,
Inactivating mutations targeting the chfr mitotic checkpoint gene in human lung cancer, Cancer Res, vol.63, pp.7185-7194, 2003. ,
Somatic mutations affect key pathways in lung adenocarcinoma, Nature, vol.455, pp.1069-75, 2008. ,
DNA repair and cell cycle control genes and the risk of young-onset lung cancer, Cancer Res, vol.66, pp.11062-11071, 2006. ,
p14 ARF activates a Tip60-dependent and p53-independent ATM/ATR/CHK pathway in response to genotoxic stress, Mol Cell Biol, vol.26, pp.4339-50, 2006. ,
URL : https://hal.archives-ouvertes.fr/inserm-00175818
Telomere length, telomeric proteins and DNA damage repair proteins are differentially expressed between primary lung tumors and their adrenal metastases, Lung Cancer, vol.65, pp.144-153, 2009. ,
53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer, Nat Cell Biol, vol.4, pp.998-1002, 2002. ,
Adda di Fagagna F. Complex engagement of DNA damage response pathways in human cancer and in lung tumor progression, Carcinogenesis, vol.28, pp.2082-2090, 2007. ,
CHK2 kinase expression is downregulated due to promoter methylation in non-small cell lung cancer, Mol Cancer, vol.3, p.14, 2004. ,
Deregulated cyclin E induces chromosome instability, Nature, vol.401, pp.297-300, 1999. ,
Cyclin E expression, a potential prognostic marker for non-small cell lung cancers, Clin Cancer Res, vol.6, pp.11-17, 2000. ,
Prognostic significance of cyclin E overexpression in resected non-small cell lung cancer, Cancer Res, vol.60, pp.242-246, 2000. ,
Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas, Proc Natl Acad Sci, vol.104, pp.4089-94, 2007. ,
Cyclin E is the only cyclindependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer, Cancer Res, vol.61, pp.647-53, 2001. ,
A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67 and ras p21: different roles of G 1 cyclins in cell proliferation and prognosis, Cancer Res, vol.61, pp.2500-2504, 2001. ,
Cyclin A and Cyclin E expression in resected non-small cell lung cancer stage I-IIIA, In Vivo, vol.23, pp.519-544, 2009. ,
Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer, Histopathology, vol.55, pp.28-36, 2009. ,
Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas, Am J Pathol, vol.153, pp.963-72, 1998. ,
Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas, Br J Cancer, vol.75, pp.1774-1782, 1997. ,
The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer, Ann Oncol, vol.15, pp.252-258, 2004. ,
Clinical implication of cyclin B1 in non-small cell lung cancer, Oncol Rep, vol.10, pp.1381-1387, 2003. ,
Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication, Cancer Res, vol.60, pp.4000-4004, 2000. ,
Alterations in cell cycle genes in early stage lung adenocarcinoma identified by expression profiling, Cancer Biol Ther, vol.2, pp.291-299, 2003. ,
Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer, Oncogene, vol.14, pp.543-552, 1997. ,
Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis, Nat Genet, vol.37, pp.883-891, 2005. ,
Expression of serine threonine kinase 15 is associated with poor differentiation in lung squamous cell carcinoma and adenocarcinoma, Pathol Int, vol.56, pp.375-80, 2006. ,